KORU Medical Systems (NASDAQ:KRMD) Rating Increased to Strong-Buy at B. Riley

B. Riley upgraded shares of KORU Medical Systems (NASDAQ:KRMD) to a strong-buy rating in a research note released on Thursday morning,Zacks.com reports.

A number of other equities analysts also recently commented on KRMD. Lake Street Capital boosted their price objective on KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research report on Tuesday, January 14th. Piper Sandler reissued a “neutral” rating and set a $4.50 price objective on shares of KORU Medical Systems in a research report on Friday, February 14th. Craig Hallum boosted their price objective on KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a research report on Friday, January 17th. Finally, Canaccord Genuity Group boosted their price objective on KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $4.70.

KORU Medical Systems Stock Up 2.6 %

Shares of NASDAQ:KRMD opened at $2.77 on Thursday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.99 and a quick ratio of 2.37. The firm has a market capitalization of $126.97 million, a PE ratio of -11.08 and a beta of 0.74. The firm’s 50-day moving average is $3.94 and its two-hundred day moving average is $3.39. KORU Medical Systems has a 1 year low of $2.04 and a 1 year high of $5.05.

Institutional Investors Weigh In On KORU Medical Systems

A number of institutional investors and hedge funds have recently added to or reduced their stakes in KRMD. Connor Clark & Lunn Investment Management Ltd. lifted its stake in KORU Medical Systems by 77.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after buying an additional 26,860 shares during the last quarter. XTX Topco Ltd purchased a new stake in KORU Medical Systems in the third quarter valued at approximately $34,000. Geode Capital Management LLC lifted its stake in KORU Medical Systems by 6.5% in the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock valued at $1,262,000 after buying an additional 28,323 shares during the last quarter. Empire Financial Management Company LLC purchased a new stake in KORU Medical Systems in the third quarter valued at approximately $259,000. Finally, Calamos Advisors LLC purchased a new stake in KORU Medical Systems in the fourth quarter valued at approximately $250,000. Hedge funds and other institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.